2-YEAR SURVIVAL - PREOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CERVICAL-CANCER STAGE-IB AND STAGE-II WITH BULKY TUMOR

被引：90

作者：

KIM, DS

MOON, H

KIM, KT

HWANG, YY

CHO, SH

KIM, SR

机构：

来源：

GYNECOLOGIC ONCOLOGY | 1989年 / 33卷 / 02期

关键词：

D O I：

10.1016/0090-8258(89)90557-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：225 / 230

页数：6

共 37 条

[1] 10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J].

BONADONNA, G ;

VALAGUSSA, P ;

ROSSI, A ;

TANCINI, G ;

BRAMBILLA, C ;

ZAMBETTI, M ;

VERONESI, U .

BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :95-115

[2]

BURGHARDT E, 1978, OBSTET GYNECOL, V52, P138

[3] ANALYSIS OF FACTORS CONTRIBUTING TO TREATMENT FAILURES IN STAGE-IB AND STAGE-II-A CARCINOMA OF THE CERVIX [J].

CHUNG, CK ;

NAHHAS, WA ;

STRYKER, JA ;

CURRY, SL ;

ABT, AB ;

MORTEL, R .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 138 (05) :550-556

[4] V-FACTOR (TUMOR VOLUME) AND T-FACTOR (FIGO CLASSIFICATION) IN THE ASSESSMENT OF CERVIX CANCER PROGNOSIS - THE RISK OF LYMPH-NODE SPREAD [J].

DARGENT, D ;

FROBERT, JL ;

BEAU, G .

GYNECOLOGIC ONCOLOGY, 1985, 22 (01) :15-22

[5]

ELLIAS EG, 1979, CANCER, V43, P1025

[6] CERVICAL-CARCINOMA - A DRUG-RESPONSIVE TUMOR - EXPERIENCE WITH COMBINED CISPLATIN, VINBLASTINE, AND BLEOMYCIN THERAPY [J].

FRIEDLANDER, M ;

KAYE, SB ;

SULLIVAN, A ;

ATKINSON, K ;

ELLIOTT, P ;

COPPLESON, M ;

HOUGHTON, R ;

SOLOMON, J ;

GREEN, D ;

RUSSELL, P ;

HUDSON, CN ;

LANGLANDS, AO ;

TATTERSALL, MHN .

GYNECOLOGIC ONCOLOGY, 1983, 16 (02) :275-281

[7]

HEYN RM, 1974, CANCER-AM CANCER SOC, V34, P2128, DOI 10.1002/1097-0142(197412)34:6<2128::AID-CNCR2820340638>3.0.CO

[8]

2-M

[9]

HOGAN WM, 1982, CANCER-AM CANCER SOC, V49, P1278, DOI 10.1002/1097-0142(19820315)49:6<1278::AID-CNCR2820490634>3.0.CO

[10]

2-R

← 1 2 3 4 →